Apretude Current Affairs, GK & News

Apretude: FDA approves injection to prevent HIV

December 22, 2021

On December 20, 2021, the Food and Drug Administration (FDA) approved world’s first injectable medication for reducing the risk of acquiring HIV. About Apretude Apretude is an injectable drug. Its generic name is “cabotegravir extended-release injectable suspension”. The drug provides an alternative to daily pills for HIV prevention, like Truvada and Descovy. According to Centers ..

Month: 

Category:  •

Topics:  • • •